Pharma stock jumps 12.7% after reporting 62% YoY increase in net profitsPharma stock jumps 12.7% after reporting 62% YoY increase in net profits

Introduction:

Leading pharma diagnostic player posted a net profit of ₹38.06 crore for Q1 FY26, marking a 62% year-on-year growth, driven by strong revenue performance and improved operating margins during the quarter.

Also Read: Water management stock jumps 5% after securing ₹2,332 Cr sea water desalination plant project in Kingdom of Saudi Arabia

Share price movement of Thyrocare Technologies:

On July 24, 2025, Thyrocare Technologies Ltd opened at ₹1,243.95, up 3.28% from its previous close of ₹1,204.45. The stock hit a high of ₹1,356.95 (12.68%) and a low of ₹1,231.50. By 10:39 AM, it was trading at ₹1,350.75, up 12.15%, with a market capitalization of ₹7,158.22 crore.

Thyrocare Q1 Net Profit Rises 62%:

Thyrocare Technologies Limited posted a 62% year-on-year rise in net profit, including exceptional items, at ₹38.06 crore for Q1 FY26, compared to ₹23.47 crore in the same quarter last year. FY25 net profit stood at ₹90.02 crore.

The company’s revenue from operations grew 23% YoY to ₹193.03 crore in Q1 FY26, up from ₹156.91 crore in Q1 FY25. For the full financial year FY25, Thyrocare reported a total revenue of ₹687.32 crore, reflecting steady growth.

EBITDA for the quarter rose 37% YoY to ₹57.46 crore, against ₹42.01 crore reported in Q1 FY25. The EBITDA for FY25 was recorded at ₹189.21 crore.

Stock performance of Thyrocare Technologies for Period of 1 week, 6 months, and 1 year:

Thyrocare Technologies Ltd delivered a 3.82% return over the past week. It gained 53.0% in the past six months, and the stock rose 57.5% over the past year.

Also Read: Semiconductor stock falls 7% after reporting 75% QoQ decline in net profits

Shareholding pattern of Thyrocare Technologies:

Particulars	Jun 2025	Mar 2025	Dec 2024
Promoter	71.10%	71.10%	71.10%
FII	3.20%	2.40%	2.80%
DII	14.50%	15.00%	14.70%
Public	11.20%	11.60%	11.50%

About Thyrocare Technologies:

Thyrocare Technologies Limited (NSE: THYROCARE) is a leading diagnostic lab network in India, offering quality, affordable testing services through 9,500+ franchises and processing over 46.9 million tests in Q1 FY26.

Stay Ahead with the Latest Stock Market Updates – Click Here

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.